{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Drug%3A+salmeterol+xinafoate&page=3", "query": { "intervention": "Drug: salmeterol xinafoate", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 90, "total_pages": 9, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Drug%3A+salmeterol+xinafoate&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Drug%3A+salmeterol+xinafoate&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-11T01:44:42.196Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00706446", "title": "The Effects of Different Long-acting Bronchodilator Medications on Asthma Patients With Different Genetic Variations", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "tiotropium bromide", "type": "DRUG" }, { "name": "Salmeterol", "type": "DRUG" }, { "name": "Formoterol", "type": "DRUG" }, { "name": "Fluticasone propionate", "type": "DRUG" }, { "name": "budesonide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 255, "start_date": "2008-06", "completion_date": "2011-09", "has_results": true, "last_update_posted_date": "2017-05-31", "last_synced_at": "2026-10-11T01:44:42.196Z", "location_count": 2, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00706446" }, { "nct_id": "NCT00452699", "title": "A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg BID To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg BID In Symptomatic Subjects With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone Propionate/salmeterol xinofoate 250/50 mcg BID", "type": "DRUG" }, { "name": "Fluticasone propionate 250 mcg BID", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 621, "start_date": "2007-05", "completion_date": "2009-05", "has_results": true, "last_update_posted_date": "2016-12-08", "last_synced_at": "2026-10-11T01:44:42.196Z", "location_count": 58, "location_summary": "Scottsdale, Arizona • Little Rock, Arkansas • Fountain Valley, California + 48 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Rancho Mirage", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00452699" }, { "nct_id": "NCT01967173", "title": "Best African American Response to Asthma Drugs", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Flovent Diskus® 100 mcg", "type": "DRUG" }, { "name": "Flovent Diskus® 250 mcg", "type": "DRUG" }, { "name": "Flovent Diskus® 500 mcg", "type": "DRUG" }, { "name": "Advair Diskus® 100/50 mcg", "type": "DRUG" }, { "name": "Advair Diskus® 250/50 mcg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Milton S. Hershey Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": null, "sex": "ALL", "summary": "5 Years and older" }, "enrollment_count": 574, "start_date": "2014-02", "completion_date": "2017-07-01", "has_results": true, "last_update_posted_date": "2018-11-15", "last_synced_at": "2026-10-11T01:44:42.196Z", "location_count": 28, "location_summary": "Tucson, Arizona • Oakland, California • San Francisco, California + 16 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Oakland", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01967173" }, { "nct_id": "NCT03240575", "title": "The ENERGITO® 2 Study Compares 2 Inhaled Medicines for Chronic Obstructive Pulmonary Disease (COPD). One Medicine is a Combination of Tiotropium and Olodaterol (Stiolto®) Taken Using the Respimat® Inhaler and the Other Medicine is a Combination of Fluticasone and Salmeterol Taken Using the Diskus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Tiotropium", "type": "DRUG" }, { "name": "Olodaterol", "type": "DRUG" }, { "name": "Fluticasone propionate", "type": "DRUG" }, { "name": "Salmeterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 302, "start_date": "2017-08-14", "completion_date": "2019-05-06", "has_results": true, "last_update_posted_date": "2020-04-16", "last_synced_at": "2026-10-11T01:44:42.196Z", "location_count": 45, "location_summary": "Jasper, Alabama • Flagstaff, Arizona • Fullerton, California + 40 more", "locations": [ { "city": "Jasper", "state": "Alabama" }, { "city": "Flagstaff", "state": "Arizona" }, { "city": "Fullerton", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Northridge", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03240575" }, { "nct_id": "NCT01225913", "title": "Mechanism(s) of Airflow Limitation During Exacerbation of Asthma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "fluticasone/salmeterol in all asthmatics", "type": "DRUG" }, { "name": "budesonide/formoterol or fluticasone/salmeterol in all asthmatics", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gelb, Arthur F., M.D.", "sponsor_class": "INDIV", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "10 Years to 80 Years" }, "enrollment_count": 50, "start_date": "2007-10", "completion_date": "2027-06", "has_results": false, "last_update_posted_date": "2023-10-26", "last_synced_at": "2026-10-11T01:44:42.196Z", "location_count": 1, "location_summary": "Lakewood, California", "locations": [ { "city": "Lakewood", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01225913" }, { "nct_id": "NCT01802723", "title": "Dose Ranging Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Periumbilical Subcutaneous Adipose Tissue Reduction" ], "interventions": [ { "name": "Drug: salmeterol xinafoate", "type": "DRUG" }, { "name": "Drug: Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Neothetics, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 472, "start_date": "2013-02", "completion_date": "2013-10", "has_results": false, "last_update_posted_date": "2015-03-26", "last_synced_at": "2026-10-11T01:44:42.196Z", "location_count": 22, "location_summary": "Beverly Hills, California • Encinitas, California • Los Angeles, California + 19 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Encinitas", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Santa Ana", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01802723" }, { "nct_id": "NCT00503009", "title": "Study Of RV-39 In Patients Who Also Have Asthma", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "fluticasone propionate/salmeterol", "type": "DRUG" }, { "name": "fluticasone propionate", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "18 Years to 40 Years" }, "enrollment_count": 16, "start_date": "2007-10", "completion_date": "2008-07", "has_results": true, "last_update_posted_date": "2016-12-28", "last_synced_at": "2026-10-11T01:44:42.196Z", "location_count": 1, "location_summary": "Charlottesville, Virginia", "locations": [ { "city": "Charlottesville", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00503009" }, { "nct_id": "NCT00296530", "title": "Study Of Patients With Allergic Rhinitis And Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "fluticasone propionate/salmeterol", "type": "DRUG" }, { "name": "fluticasone propionate", "type": "DRUG" }, { "name": "montelukast", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "15 Years", "maximum_age": null, "sex": "ALL", "summary": "15 Years and older" }, "enrollment_count": 600, "start_date": "2005-09", "completion_date": "2007-07", "has_results": false, "last_update_posted_date": "2016-10-28", "last_synced_at": "2026-10-11T01:44:42.196Z", "location_count": 80, "location_summary": "Ozark, Alabama • Tempe, Arizona • Little Rock, Arkansas + 67 more", "locations": [ { "city": "Ozark", "state": "Alabama" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00296530" }, { "nct_id": "NCT00395304", "title": "Childhood Asthma Research and Education (CARE) Network Trial - Best Add-On Therapy Giving Effective Response (BADGER)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "fluticasone propionate + montelukast", "type": "DRUG" }, { "name": "fluticasone propionate", "type": "DRUG" }, { "name": "fluticasone propionate + salmeterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Milton S. Hershey Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "6 Years to 18 Years" }, "enrollment_count": 182, "start_date": "2007-03", "completion_date": "2011-12", "has_results": true, "last_update_posted_date": "2018-07-02", "last_synced_at": "2026-10-11T01:44:42.196Z", "location_count": 5, "location_summary": "Tucson, Arizona • San Diego, California • Denver, Colorado + 2 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "San Diego", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT00395304" }, { "nct_id": "NCT07396987", "title": "Boosting Referrals to Asthma Specialists for Patients Seen at the Emergency Room for an Asthma Exacerbation", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Asthma Attack", "Asthma Control", "Asthma Exacerbations", "Asthma" ], "interventions": [ { "name": "ER-Initiated Telehealth Referral", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Juan Carlos Cardet", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2026-07-19", "completion_date": "2027-08", "has_results": false, "last_update_posted_date": "2026-09-14", "last_synced_at": "2026-10-11T01:44:42.196Z", "location_count": 1, "location_summary": "Tampa, Florida", "locations": [ { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07396987" } ] }